Nxera Pharma
(OTC) SOLTF
Nxera Pharma Financials at a Glance
Market Cap
$553.84MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
¥34.40B
Net Income (TTM)
-¥10.00B
EPS (TTM)
-$0.75
P/E Ratio
-8.15
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Price
$5.99
Volume
100
Open
$5.99
Price
$5.99
Volume
100
Open
$5.99
Previous Close
$5.99
Daily Range
$5.99 - $5.99
52-Week Range
$4.90 - $7.94
Estimated Earnings Date
Aug 7, 2026
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Price
$5.99
Volume
100
Open
$5.99
Previous Close
$5.99
Daily Range
$5.99 - $5.99
52-Week Range
$4.90 - $7.94
Estimated Earnings Date
Aug 7, 2026
SOLTF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nxera Pharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
382
CEO
Chris Cargill
Website
www.nxera.lifeHeadquarters
Tokyo, TY 102-0083, JP
SOLTF Financials
Key Financial Metrics (TTM)
Gross Margin
77.50%
Operating Margin
-6.59%
Net Income Margin
-29.15%
Return on Equity
-15.58%
Return on Capital
-6.83%
Return on Assets
-7.48%
Earnings Yield
-12.27%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$553.84MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
92.46M
Volume
100
Avg. Volume
1.72K
Financials (TTM)
Gross Profit
¥26.65B
Operating Income
-¥2.57B
EBITDA
¥3.09B
Operating Cash Flow
-¥4.99B
Capital Expenditure
-¥646.04M
Free Cash Flow
-¥5.63B
Cash & ST Invst.
¥11.67B
Total Debt
¥56.18B
Nxera Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
¥11.33B
+70.5%
Gross Profit
¥10.20B
+102.9%
Gross Margin
90.07%
N/A
Market Cap
$553.84MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.43M
N/A
Employees
387
N/A
Net Income
¥1.80B
+337.4%
EBITDA
¥4.67B
+520.4%
Quarterly Fundamentals
Total Cash
¥11.67B
-66.1%
Total Debt
¥56.18B
-15.2%
Accounts Receivable
¥14.15B
+217.2%
Inventory
¥11.23B
+28.1%
Long Term Debt
¥49.44B
-17.0%
Short Term Debt
¥6.74B
+0.8%
Return on Assets
-7.48%
N/A
Return on Invested Capital
-1.90%
N/A
Free Cash Flow
-¥1.97B
-490.9%
Operating Cash Flow
-¥1.66B
-371.5%